RxDoctor Payments Data

Charles Hannon, MD

Adult Reconstructive Orthopaedic Surgery · Rochester, MNNPI 1417339375

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.2%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Encore Medical, LP at 55.3% of the total. 2025 is the largest year on record at $168,683, more than ten times the $790 reported in 2019.

$225,039in general payments, 2019–2025

Across 137 payments — averaging $1642.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$124K
  • Zimmer Biomet$74K
  • Vertex$14K
  • Signature Orthopaedics USA Corp$9K
  • Stryker$3K
  • Arteriocyte Medical Systems, Inc.$264
  • plus $844 from 6 others
$380,645in research payments, 2019–2025

Across 18 payments — averaging $21,147 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$196K
  • Smith+Nephew$184K

What the payments were for

  • Royalty or licence$73,13032%
  • Consulting fees$117,37552%
  • Travel & lodging$28,59013%
  • Food & beverage$5,5692%
  • Education$3740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$203,344
Medicare patients
282
Services billed
2,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam21$73

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →